You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
When Should Iatrogenic Polypharmacy Be Considered a Disease?
AMA Journal of Ethics, December 2018
The data shown below were collected from the profiles of 67 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Korea, Republic of||1||1%|
|Members of the public||61||91%|
|Practitioners (doctors, other healthcare professionals)||3||4%|
The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Bachelor||2||20%|
|Student > Ph. D. Student||1||10%|
|Student > Master||1||10%|
|Professor > Associate Professor||1||10%|
|Readers by discipline||Count||As %|
|Biochemistry, Genetics and Molecular Biology||2||20%|
|Pharmacology, Toxicology and Pharmaceutical Science||1||10%|
|Agricultural and Biological Sciences||1||10%|
|Medicine and Dentistry||1||10%|